John W. Pietrowicz's most recent trade in CME Group Inc - Ordinary Shares - Class A was a trade of 4,716 Common Stock Class A done . Disclosure was reported to the exchange on Sept. 15, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| CME Group (Class A) | John W. Pietrowicz | Sr MD Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2022 | 4,716 | 55,625 (0%) | 0% | 0 | Common Stock Class A | |
| CME Group (Class A) | John W. Pietrowicz | Sr MD Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 190.77 per share. | 15 Sep 2022 | 958 | 50,909 (0%) | 0% | 190.8 | 182,758 | Common Stock Class A |
| CME Group (Class A) | John W. Pietrowicz | Sr MD Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 191.56 per share. | 15 Sep 2022 | 387 | 55,238 (0%) | 0% | 191.6 | 74,134 | Common Stock Class A |
| CME Group (Class A) | John W. Pietrowicz | Sr MD Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 191.30 per share. | 14 Sep 2022 | 446 | 51,867 (0%) | 0% | 191.3 | 85,320 | Common Stock Class A |
| CME Group (Class A) | John W. Pietrowicz | Sr MD Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 232.00 per share. | 15 Mar 2022 | 3,290 | 53,644 (0%) | 0% | 232 | 763,280 | Common Stock Class A |
| CME Group (Class A) | John W. Pietrowicz | Sr MD Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 232.00 per share. | 15 Mar 2022 | 1,331 | 52,313 (0%) | 0% | 232 | 308,792 | Common Stock Class A |
| CME Group (Class A) | John W. Pietrowicz | Sr MD Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 188.69 per share. | 16 Sep 2021 | 407 | 50,354 (0%) | 0% | 188.7 | 76,797 | Common Stock Class A |
| CME Group (Class A) | John W. Pietrowicz | Sr MD Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2021 | 4,368 | 50,761 (0%) | 0% | 0 | Common Stock Class A | |
| CME Group (Class A) | John W. Pietrowicz | Sr MD Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 188.96 per share. | 14 Sep 2021 | 537 | 46,915 (0%) | 0% | 189.0 | 101,472 | Common Stock Class A |
| CME Group (Class A) | John W. Pietrowicz | Sr MD Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 188.96 per share. | 14 Sep 2021 | 522 | 46,393 (0%) | 0% | 189.0 | 98,637 | Common Stock Class A |
| CME Group (Class A) | John W. Pietrowicz | Sr MD Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 188.85 per share. | 14 Sep 2021 | 470 | 47,452 (0%) | 0% | 188.9 | 88,760 | Common Stock Class A |
| CME Group (Class A) | John W. Pietrowicz | Sr MD Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 209.09 per share. | 15 Mar 2021 | 9,398 | 51,728 (0%) | 0% | 209.1 | 1,965,028 | Common Stock Class A |
| CME Group (Class A) | John W. Pietrowicz | Sr MD Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 209.09 per share. | 15 Mar 2021 | 3,806 | 47,922 (0%) | 0% | 209.1 | 795,797 | Common Stock Class A |